비뇨의학 Urology DigestISSN:2713-7910(Print) 2733-5453(Online)대한비뇨의학과의사회

Smith DP et al., Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based study, PLoS One, 2014 10.1371/journal.pone.010927825333345PMC4198085

Sexton CC et al., The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS, BJU Int, 2009 10.1111/j.1464-410X.2009.08369.x19302498

Poyhonen A et al., Empirical evaluation of grouping of lower urinary tract symptoms: principal component analysis of Tampere Ageing Male Urological Study data, BJU Int, 2013 10.1111/j.1464-410X.2012.11593.x23106935

Gormley EA et al., Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline, J Urol, 2012 10.1016/j.juro.2012.09.07923098785

Lerner LB et al., Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management, J Urol, 2021 10.1097/JU.000000000000218334384237

Chapple CR et al., A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial, Eur Urol, 2005 10.1016/j.eururo.2005.05.01515990220

Ginsberg D et al., Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder, BJU Int, 2013 10.1111/bju.1217423826844

Kaplan SA et al., Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial, JAMA, 2006 10.1001/jama.296.19.231917105794

Sakalis V et al., Detrusor overactivity may be a prognostic factor for better response to combination therapy over monotherapy in male patients with benign prostatic enlargement and storage lower urinary tract symptoms, Int Neurourol J, 2021 10.5213/inj.2040188.09433378614PMC8022163

Kaplan SA et al., Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency, J Urol, 2013 10.1016/j.juro.2012.11.030

Singh I et al., Efficacy and safety of tamsulosin vs its combination with mirabegron in the management of lower urinary tract non-neurogenic overactive bladder symptoms (OABS) because of Benign Prostatic Enlargement (BPE)-An open label randomised controlled clinical study, Int J Clin Pract, 2021 10.22541/au.160765069.91197704/v1

Matsuo T et al., The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with alpha1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men, BMC Urol, 2016 10.1186/ISRCTN16759097

Matsukawa Y et al., Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies, Neurourol Urodyn, 2019 10.1002/nau.2393530779375

Aikawa K et al., Elucidation of the pattern of the onset of male lower urinary tract symptoms using cluster analysis: Efficacy of tamsulosin in each symptom group, Urology, 2015 10.1016/j.urology.2015.04.03626194300

Pinggera GM et al., alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms, BJU Int, 2008 10.1111/j.1464-410X.2007.07339.x18005199

Matsukawa Y et al., Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study, Int J Urol, 2014 10.1111/iju.1243824661225

Montorsi F et al., The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study, BJU Int, 2011 10.1111/j.1464-410X.2011.10129.x21348912

Jiang YH et al., Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment, PLoS One, 2018 10.1371/journal.pone.019070429462145PMC5819762